Douglas J. Mitchell
Douglas J. Mitchell publishes mostly in Neurology, Genetics and Surgery, on topics such as Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research and Parkinson's Disease Mechanisms and Treatments.
- World rank
- #836,989 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #69,218 of 367,258
- Works
- 30
- Citations
- 3.3k
- Citations per work
- 111.4
What does Douglas J. Mitchell research?
Douglas J. Mitchell's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (4%), Psychology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1447.4%
- Medicine1447.4%
- Everything else1445.0%
- Life Sciences13.8%
- Social Sciences13.8%
- Psychology13.8%
- 1Neurology30% of their works
- 2Genetics8% of their works
- 3Surgery6% of their works
- 4Pulmonary and Respiratory Medicine4% of their works
- 5Molecular Biology4% of their works
- 6Clinical Psychology4% of their works
Research topics
- Amyotrophic Lateral Sclerosis Research
- Neurogenetic and Muscular Disorders Research
- Parkinson's Disease Mechanisms and Treatments
- Prion Diseases and Protein Misfolding
- Parkinson's Disease and Spinal Disorders
- Genetic Neurodegenerative Diseases
- Spinal Cord Injury Research
- Palliative Care and End-of-Life Issues
Which keywords describe Douglas J. Mitchell's research?
The keywords of their largest research topics: Neurodegeneration, FUS/TLS, TDP-43, Parkinson's Disease, Mitochondrial Dysfunction, SMN1, Spinal Muscular Atrophy and Protein Aggregation.
- Spinal Cord Injury
- Palliative Care
- Huntington's Disease
- Prion Diseases
- Dropped Head Syndrome
- a-Synuclein
- Protein Aggregation
- SMN1
- Parkinson's Disease
- FUS/TLS
- Neurodegeneration
- TDP-43
- Mitochondrial Dysfunction
- Spinal Muscular Atrophy
- Dopaminergic Neurons
- Camptocormia
- Molecular Basis
- End-of-Life
- Neurological Classification
- Polyglutamine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurodegeneration202 topics
- FUS/TLS161 topic
- TDP-43161 topic
- Parkinson's Disease72 topics
- Mitochondrial Dysfunction62 topics
- SMN161 topic
- Spinal Muscular Atrophy61 topic
- Protein Aggregation52 topics
- Dopaminergic Neurons41 topic
- a-Synuclein41 topic
- Camptocormia31 topic
- Dropped Head Syndrome31 topic
- Molecular Basis31 topic
- Prion Diseases31 topic
- End-of-Life21 topic
- Huntington's Disease21 topic
- Neurological Classification21 topic
- Palliative Care21 topic
- Polyglutamine21 topic
- Spinal Cord Injury21 topic
Where does Douglas J. Mitchell work?
Douglas J. Mitchell's main affiliation in the publication record is Royal Preston Hospital, United Kingdom.
How many publications and citations does Douglas J. Mitchell have?
OpenAlex counts 30 works and 3,343 citations for Douglas J. Mitchell, an h-index of 17, ranking #836,989 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Douglas J. Mitchell. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.